Senté expands newly launched cosmeceutical line in the US

The San Diego-based cosmeceutical company has entered into a strategic partnership in an effort to expand its line of skin care products featuring proprietary glycoprotein technology that combats aging skin.

The venture with dermatology conglomerate Scripps Health, will now see the Senté Dermal Repair Cream available to consumers throughout Dermatology Centers in Southern California.

"Recent studies have validated the importance of heparan sulfate in repairing skin conditions related to UV exposure and aging - I am pleased to offer this treatment option to my patients," says Edward Ross, M.D., director of Scripps Laser and Cosmetic Dermatology Center.

How it works

HS is the most biologically active of the glycoproteins that reside naturally in human skin, and is responsible for regulating a wide variety of biological activities within the body. 

Found on the surface of skin cells and through the epidermal and dermal layers, the active plays an intricate part in the new formulation that is promising cell renewal, collagen development, skin hydration, and the lightening of pigmented lesions.

According to Sente founder Kleanthis G. Xanthopoulos, this active helps to promote cell renewal, facilitate new collagen development, increase skin hydration, gradually lighten the appearance of pigmented lesions and soothe irritated skin.

"The molecule binds and regulates the activities of enzymes, growth factors and proteins, and even has the ability to stimulate collagen fiber production, providing long lasting benefits by addressing age-related issues of elasticity loss and skin tone."

The product line was launched after scientists were employed to further delve into the importance of glycoproteins for the skin in Senté’s labs at the University of California.

According to the chief of the University’s division of dermatology, Richard L. Gallo; "We are learning more everyday about how critical glycoproteins are to help turn back the aging process for the skin." 

Popular technology

Back in July, biotechnology company Makucell also launched a cosmetic active based on proprietary technology to combat skin aging. The ingredient, Asymmate, was described as influencing the gene co-activator choice used by β-catenin to encourage skin stem cell differentiation.

Then, Michael Kahn and his team of scientists at the Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at the University of Southern California suggested that using a cream with Asymmtate may reverse gene expression changes associated with aging skin and with lentigines.